Global Vitamin D Market Size, Share, Opportunities, And Trends By Analog Type (Vitamin D2, Vitamin D3), By Application (Animal Feed & Pet Food, Functional Food & Beverages, Personal Care, Pharmaceuticals), By End-User (Children, Adults, Pregnant Women), And By Geography - Forecasts From 2023 To 2028

  • Published : Mar 2023
  • Report Code : KSI061614494
  • Pages : 138

Vitamin D is a vitamin that the body needs in very little levels to function and keep itself healthy. Vitamin D3 and vitamin D2 are the two primary forms of vitamin D. Animal-based foods including oil, egg yolk, butter, and nutritional supplements are the major sources of vitamin D3. It aids the body in absorbing calcium and is also known as cholecalciferol. The three IU strengths of vitamin D—500,000, 100,000, and 40 MIU—are offered in both oil and powder form. Adults, expectant mothers, and kids can all utilize it.

Some factors driving the growth of the global market include rising consumer awareness of the need of eating a healthy diet, rising consumer spending capacity on their well-being, particularly in the developed area, and widespread availability of vitamin D products worldwide.

Due to extensive fortification activities governments across the world undertake, dietary supplements are constantly changing to appeal to specialty demographic groups (pregnant and nursing women, elderly nutrition, and pediatric nutrition). Positive attitudes regarding the vitamin supplement business have resulted from the rising awareness of vitamin supplements.

For instance in April 2022, Arachitol Gummies, a form of nutritional supplement that aids in maintaining necessary levels of vitamin D, were also introduced in India according to Abbott, a top producer of healthcare products and services worldwide. The product is now available in orange taste and has received approval from India's Food Safety and Standards Administration. Filling up dietary deficiencies is a vital step that improves bodily wellness.

The market for vitamin D will expand due to the rise in cases of osteoporosis in women.

Osteoporosis is a bone disease that occurs when bone mass and mineral density decline or when the composition and strength of bone alter. As a result, there may be a decline in bone density and an elevated risk of fractures (broken bones). Other causes include having a family history of osteoporosis, parents who have had hip fractures, having a lower body mass index (BMI), and being a woman because her bones are smaller and thinner than men's. As vitamin D is a necessary ingredient that aids the body in absorbing calcium and phosphorus from diet and aids in the development of stronger bones in women after menopause, the prevalence of osteoporosis in women will increase, resulting in a high need for vitamin D. It also aids in the treatment of conditions that weaken bones. For instance, the International Osteoporosis Foundation (IOF) estimates that in Europe by 2025, there would be over 25.5 million women (22.1% of women over 50) who have osteoporosis.

Faster-acting vitamin D supplements to surge market expansion.

The cutting-edge fast-acting vitamin D supplements work well to treat severe vitamin D insufficiency in patients and hasten their recovery. To boost their market share, major manufacturers are concentrating on providing faster-acting vitamin D supplements. For instance, Royal DSM, a chemical firm with a focus on nutrition, health, and sustainable living, launched ampli-D in Australia in March 2021. This product is a fast-acting vitamin D supplement.

It is a quicker and more efficient supplement that enables the body to reach sufficient vitamin D levels to promote immunological function in days and weeks as opposed to months. The product claims to work three times as quickly and effectively as traditional vitamin D3 doses.

Asia Pacific is projected to be the prominent market shareholder in the vitamin D market and is anticipated to continue throughout the forecast period.

With a holding of a sizable market revenue share, the Asia Pacific region is predicted to dominate the market and is expected to keep doing so for the duration of the forecast period. Major factors influencing the growth and demand of the industry in the region include the simple accessibility of raw materials like milk and the region's consistently expanding consumer disposable income. Due to the high incidence of numerous non-communicable illnesses in the nation, Malaysia also has a higher vitamin D deficit than other parts of the world.

Additionally, due to greater consumer knowledge of the numerous health advantages linked to vitamin D use, the North American area is anticipated to have significant growth in the upcoming years. However, because Canadians do not consume enough vitamin D for their bodies, they have low vitamin D levels due to a lack of vitamin D in their diet alone. The frequency of insufficient intakes was almost 90% across the majority of age and gender categories, according to data from the Canadian Community Health Survey.

Market Key Developments

  • In November 2022, D-Mulsion 2500 and D3 2500, two new and enhanced vitamin D supplements from Genestra Brands, assist to lower vitamin D deficiency and the risk of developing osteoporosis.
  • In October 2022, With the introduction of its "Xtend Healthy Hydration Sticks," Xtend, a Nutrabolt, broadened the range of amino acids for hydration and recovery. It is an electrolyte supplement for on-the-go use that provides hydration with no added sugar and is also a significant source of vitamins B and D. The sticks are offered in three flavors: raspberry lemonade, strawberry banana, and lemon-lime.
  • In July 2022, A vitamin D3 and magnesium supplement called Pure D3 Plus has been introduced by KaraMD, a US-based firm. The substance was introduced to improve bone and heart health as well as immunity. They include the capacity to lower the chances of certain illnesses, such as cardiovascular disorders.


  • By Analog Type
    • Vitamin D2
    • Vitamin D3
  • By Application
    • Animal feed & pet food
    • Functional food & beverages
    • Personal care
    • Pharmaceuticals
  • By End-User
    • Children
    • Adults
    • Pregnant Women
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Taiwan
      • Thailand
      • Indonesia
      • Others


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Vitamin D2

5.3. Vitamin D3


6.1. Introduction

6.2. Animal feed & pet food

6.3. Functional food & beverages

6.4. Personal care

6.5. Pharmaceuticals


7.1. Introduction

7.2. Children

7.3. Adults

7.4. Pregnant Women


8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others


9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix


10.1. BASF

10.2. DSM

10.3. Fermenta Biotech Ltd.

10.4. Zhejiang Medicine Co., Ltd.

10.5. Zhejiang Garden Biochemical High-Tech Co., Ltd

10.6. Glanbia

10.7. Nestle SA

10.8. Pfizer, Inc.

10.9. Zhejiang Xinhecheng Co., Ltd

10.10. McKinley Resources Inc.



Fermenta Biotech Ltd.

Zhejiang Medicine Co., Ltd.

Zhejiang Garden Biochemical High-Tech Co., Ltd


Nestle SA

Pfizer, Inc.

Zhejiang Xinhecheng Co., Ltd

McKinley Resources Inc.